No abstract

Despite an array of preventive global public health interventions, SARS-CoV-2 has continued to spread significantly, infecting millions of people across the globe weekly. Newer variants of interest and concern have continued to emerge, placing the need for policymakers to rethink prevention strategies to end the pandemic. The approval of SARS-CoV-2 vaccines for public health use in December 2020 was seen as a significant development towards pandemic control and possibly ending the pandemic. However, breakthrough infections have continued to be observed among the ‘fully vaccinated’, and the duration and sustainability of vaccine-induced immunity has remained a topical public health discourse. In the absence of accurate public health communication, the breakthrough infections and waning immunity concepts have potential to further compound vaccine hesitancy. With this viewpoint, we discuss breakthrough SARS-CoV-2 infections, waning immunity, the need for COVID-19 booster shots, vaccine inequities, and the need to address vaccine hesitancy adequately to propel global vaccination programs forward.

Zimbabwe reported its first case of coronavirus disease 2019 (COVID-19) on 20 March 2020 and the country’s response has largely adhered to international protocols. From the outset of the pandemic, most control measures were premised upon knowledge of breaking infectious diseases’ chains of transmission gained from previous experiences with comparable pathogens. As relatively little was known about the novel virus, and the prospects of effective vaccines were not on the horizon, these tough control measures were deemed appropriate. Two years into the pandemic, a massive evolution of knowledge has transpired, and safe and effective vaccines against the virus are now available, are administered to billions of people, and can significantly reduce new infections, severe disease, hospitalisation, and death from the disease. Based on the understanding of the pandemic and the need to restore socio-economic activities, in this review we propose a paradigm shift in addressing the challenges of the COVID-19 pandemic. The COVID-19 response should take into consideration the local context and tailor-make a response that addresses local challenges.

Control measures for the COVID‐19 pandemic brought unprecedented challenges to health care delivery. Some countries in sub‐Saharan Africa (SSA) stopped the provision of essential health care except for those services that were deemed emergencies or life‐threatening. A rapid review was conducted on March 18, 2022, on the accessibility and utilization of antenatal care services in sub‐Saharan Africa during the COVID‐19 pandemic. PubMed, Google Scholar, SCOPUS, and the World Health Organization library databases were searched for relevant studies. A modified Population, Intervention, Control, and Outcomes (PICO) framework informed the development of the search strategy. The review included studies conducted within Africa that described the availability, access, and utilization of antenatal services during the COVID‐19 pandemic. Eighteen studies met the inclusion criteria. This review revealed a reduction in access to ANC services, an increase in the number of home deliveries, and a reduction in the number of women attending ANC visits during the COVID‐19 pandemic. A decrease in ANC service utilization was reported in some studies in the review. Barriers to ANC access and utilization during the COVID‐19 pandemic included movement restrictions, limited transport access, fear of contracting COVID‐19 at the health facilities, and facility barriers. The use of telemedicine needs to be improved in African countries to allow for the continued provision of health services during pandemics. In addition, there should strengthening of community involvement in the provision of maternal health services post‐COVID‐19 so that services may be able to better withstand future public health emergencies.

Wastewater-based epidemiology for SARS-CoV-2 RNA detection in wastewater is desirable for understanding COVID-19 in settings where financial resources and diagnostic facilities for mass individual testing are severely limited. We conducted a rapid review to map research evidence on the utilization of SARS-CoV-2 wastewater surveillance in Africa. We searched PubMed, Google Scholar, and the World Health Organization library databases for relevant reports, reviews, and primary observational studies. Eight studies met the inclusion criteria. Narrative synthesis of the findings from included primary studies revealed the testing methodologies utilized and that detected amount of SARS-CoV-2 viral RNA correlated with the number of new cases in the studied areas. The included reviews revealed the epidemiological significance and environmental risks of SARS-CoV-2 wastewater. Wastewater surveillance data at the community level can be leveraged for the rapid assessment of emerging threats and aid pandemic preparedness. Our rapid review revealed a glaring gap in the primary literature on SARS-CoV-2 wastewater surveillance on the continent, and accelerated and adequate investment into research is urgently needed to address this gap.